The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception · 2026
Contraception for transgender and gender diverse people.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lami Alessandra, Farris Manuela, Meriggiola Maria Cristina
Аннотация
INTRODUCTION: Contraceptive counselling and contraception prescription in transgender and gender-diverse (TGD) individuals remain an underrecognized aspect of TGD care, and dedicated recommendations are still limited.
METHODS: This Expert Opinion aims to provide up-to-date practical guidance for clinicians on this topic, based on a comprehensive review of the available literature, current international recommendations, and the authors' clinical experience.
RESULTS: It reviews the available contraceptive options, including short-acting and long-acting reversible contraceptives, barrier methods, and permanent contraception, discussing their advantages, limitations, and clinical applicability in the context of gender-affirming hormone therapy (GAHT). Particular attention is paid to contraceptive counselling, menstrual suppression, management of unscheduled bleeding, and practical aspects that may influence contraceptive choice and adherence in TGD population.
CONCLUSION: This Expert Opinion provides practical recommendations to support individualised contraceptive counselling and evidence-informed contraceptive prescribing, with the aim of improving reproductive healthcare and promoting informed shared decision-making for TGD individuals.
METHODS: This Expert Opinion aims to provide up-to-date practical guidance for clinicians on this topic, based on a comprehensive review of the available literature, current international recommendations, and the authors' clinical experience.
RESULTS: It reviews the available contraceptive options, including short-acting and long-acting reversible contraceptives, barrier methods, and permanent contraception, discussing their advantages, limitations, and clinical applicability in the context of gender-affirming hormone therapy (GAHT). Particular attention is paid to contraceptive counselling, menstrual suppression, management of unscheduled bleeding, and practical aspects that may influence contraceptive choice and adherence in TGD population.
CONCLUSION: This Expert Opinion provides practical recommendations to support individualised contraceptive counselling and evidence-informed contraceptive prescribing, with the aim of improving reproductive healthcare and promoting informed shared decision-making for TGD individuals.